Filing Details
- Accession Number:
- 0001140361-16-060224
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2016-04-05 15:30:13
- Reporting Period:
- 2016-04-01
- Filing Date:
- 2016-04-05
- Accepted Time:
- 2016-04-05 15:30:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1367644 | Emergent Biosolutions Inc. | EBS | Pharmaceutical Preparations (2834) | 141902018 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1380956 | Robert Kramer | 400 Professional Dr, Suite 400 Gaithersburg MD 20879 | Evp, Corporate Services Divisi | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2016-04-01 | 11,531 | $14.41 | 91,607 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-04-01 | 11,531 | $35.49 | 80,076 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-04-01 | 3,939 | $14.67 | 84,015 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-04-01 | 3,939 | $35.74 | 80,076 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-04-01 | 17,354 | $28.09 | 97,430 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-04-01 | 17,354 | $35.48 | 80,076 | No | 4 | S | Direct | |
Common Stock | Acquisiton | 2016-04-01 | 5,503 | $29.00 | 85,579 | No | 4 | M | Direct | |
Common Stock | Disposition | 2016-04-01 | 5,503 | $35.66 | 80,076 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-04-01 | 445 | $35.93 | 79,631 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-04-01 | 1,855 | $35.80 | 77,776 | No | 4 | S | Direct | |
Common Stock | Disposition | 2016-04-01 | 2,945 | $35.73 | 74,831 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | M | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Stock Option | Acquisiton | 2016-04-01 | 11,531 | $0.00 | 11,531 | $14.41 |
Common Stock | Stock Option | Acquisiton | 2016-04-01 | 3,939 | $0.00 | 3,939 | $14.67 |
Common Stock | Stock Option | Acquisiton | 2016-04-01 | 17,354 | $0.00 | 17,354 | $28.09 |
Common Stock | Stock Option | Acquisiton | 2016-04-01 | 5,503 | $0.00 | 5,503 | $29.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
11,531 | 2019-11-04 | No | 4 | M | Direct | |
3,940 | 2020-03-11 | No | 4 | M | Direct | |
34,708 | 2021-03-10 | No | 4 | M | Direct | |
27,514 | 2022-03-09 | No | 4 | M | Direct |
Footnotes
- Consists of an option granted under the company's stock incentive plan on November 5, 2012.
- Consists of an option granted under the company's stock incentive plan on March 12, 2013.
- Consists of an option granted under the company's stock incentive plan on March 11, 2014.
- Consists of an option granted under the company's stock incentive plan on March 10, 2015.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.11 to $36.34, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.37 to $36.32, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.07 to $36.35, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.12 to $36.42, inclusive.
- Consists of restricted stock units granted under the Amended and Restated Emergent BioSolutions Inc. 2006 Stock Incentive Plan, as amended.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.91 to $36.00, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.13, inclusive.
- The price reported is a weighted average price. These shares were sold in multiple transactions at prices ranging from $35.50 to $36.32, inclusive.
- The option vested in three equal installments in November 2013, 2014 and 2015.
- The option vest in three equal installments in March 2014, 2015 and 2016.
- The option vest in three equal installments in March 2015, 2016 and 2017.
- The option vest in three equal installments in March 2016, 2017 and 2018.